In 2025, Life Sciences and Health Care (LS&HC) companies face rapidly evolving regulatory paradigms that create transactional risks and require daily monitoring. After more than 70 national elections in 2024, the dust hasn’t...more
8/25/2025
/ Artificial Intelligence ,
Clinical Trials ,
Cybersecurity ,
Digital Health ,
Environmental Social & Governance (ESG) ,
Genetic Materials ,
Government Agencies ,
Healthcare ,
Healthcare Reform ,
Innovative Technology ,
Life Sciences ,
Pharmaceutical Industry ,
Public Health ,
Regulatory Oversight ,
Regulatory Reform ,
Regulatory Requirements ,
Risk Management ,
Supply Chain ,
Trump Administration
The Singapore Exchange (SGX) expects issuers to manage global sanctions risk, not just the risk from Singapore-imposed sanctions. Sanctions risks need to managed on a group-wide basis, including subsidiaries and affiliates...more
In an era where digital transactions are increasingly vulnerable to sophisticated fraud, regulators around the world are stepping up to enhance consumer protection and cybersecurity. Singapore's Shared Responsibility...more
1/14/2025
/ Banking Sector ,
Banks ,
Compliance ,
Cybersecurity ,
EU ,
Financial Institutions ,
Fraud ,
Regulatory Agenda ,
Regulatory Reform ,
Regulatory Requirements ,
Singapore ,
UK
In 2020, heightened demand for health care resulted in an influx of therapeutic goods being included on the Australian Register of Therapeutic Goods (ARTG). A large portion of these goods are manufactured in China however,...more
3/18/2021
/ Australia ,
China ,
Coronavirus/COVID-19 ,
Infectious Diseases ,
Life Sciences ,
Manufacturers ,
Masks ,
Medical Devices ,
Personal Protective Equipment ,
Pharmaceutical Industry ,
Public Health ,
Regulatory Requirements ,
Supply and Demand ,
Supply Chain